Israel Englander’s St Jude Medical STJ Stock Holding History

Israel Englander’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-150,000	Closed	-$11M	–	3943
2015 Q2	$11M	Buy	150,000 +35,300	+31%	+$2.55M	0.02%	927
2015 Q1	$7.5M	Sell	114,700 -110,600	-49%	-$7.35M	0.01%	1192
2014 Q4	$14.7M	Buy	225,300 +219,700	+3,923%	+$14.1M	0.03%	759
2014 Q3	$337K	Buy	5,600 +1,300	+30%	+$84.9K	﹤0.01%	3002
2014 Q2	$298K	Sell	4,300 -17,600	-80%	-$1.14M	﹤0.01%	2879
2014 Q1	$1.43M	Buy	+21,900	New	+$1.43M	﹤0.01%	2013

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Israel Englander's STJ Position: Q1 2017 in Review

Israel Englander sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,353,910 shares — an estimated $109M sold.

Israel Englander first reported a position in STJ in Q2 2013 and held it in 14 quarters. The position peaked at $121M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Israel Englander reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Israel Englander sold 1,353,910 St Jude Medical shares in Q1 2017, an estimated $109M.
Israel Englander first reported a position in St Jude Medical in Q2 2013 and held it in 14 quarters.
Israel Englander's St Jude Medical position peaked at $121M in Q3 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.